Clinical trial
Efficacy and Safety Study of Benralizumab in Adults and Adolescents Inadequately…
NCT01914757 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT01914757 |
|---|---|
| Title | Efficacy and Safety Study of Benralizumab in Adults and Adolescents Inadequately Controlled on Inhaled Corticosteroid Plus Long-acting β2 Agonist |
| Official title | A Multicentre, Randomized, Double-blind, Parallel Group, Placebocontrolled, Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Asthmatic Adults and Adolescents Inadequately Controlled on Inhaled Corticosteroid Plus Long-acting β2 Agonist (CALIMA) |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Biological |
| Interventions | Benralizumab, Placebo |
| Enrollment | 2,508 |
| Start date | Aug 1, 2013 |
| Primary completion | Mar 1, 2016 |
| Completion | Mar 1, 2016 |
| First posted | Aug 2, 2013 |
| Last update posted | Jan 25, 2017 |
| Countries | Argentina, Canada, Chile, Germany, Japan, Philippines, Poland, Romania, Sweden, Ukraine, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: